
BioGntx
BioGntx uses its patented NLC delivery platform to help companies make hard-to-formulate active ingredients more stable, more dispersible and more bioavailable in the Nutraceutical, Cosmetic and Pharma sectors. Visite our website.

BioGntx uses its patented NLC delivery platform to help companies make hard-to-formulate active ingredients more stable, more dispersible and more bioavailable in the Nutraceutical, Cosmetic and Pharma sectors. Visite our website.

INFECTA is a clinical research organization focused on accelerating the development of infectious disease products through early-phase clinical testing. INFECTA’s approach centers on efficient clinical trials using smart study design,

Mireca Medicines GmbH is an expanding, preclinical stage company pioneering the development of proprietary cyclic guanosine monophosphate (cGMP)-analogs and drug delivery technologies to treat diseases caused by a dysregulation of

Orfenix is a venture builder that creates and manages projects to move an idea from the lab to market authorisation by creating and augmenting teams with relevant expertise around key

The Institute of Environmental Sciences (CML) at Leiden University is at the forefront of industrial ecology, environmental biology, and sustainability science. We aim to remain a global leader in sustainability

Assess true kinase selectivity in living cells. Measuring drug selectivity where it truly matters. We provide definitive, in-cell target engagement and selectivity data to de-risk and accelerate your drug discovery pipeline.

Accurate, Fast, and Reliable Genetic Insights. Visit our website.






Platform technology for intracellulair delivery of bioactive molecules. Visit our website



Preventing and helping reduce (over)sensitive inflammatory processes in brain, eyes, skin, lungs Visit our website

Discover the infinite power of partnership to drive scientific discovery. Visit our website
